Dr. Livingston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Retired from MSKCC 7/1/2011
New York, NY 10075- Is this information wrong?
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1971 - 1972
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1969 - 1971
Harvard Medical SchoolClass of 1969
Certifications & Licensure
NY State Medical License 1970 - 2021- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2006
Clinical Trials
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma Start of enrollment: 1999 Jun 01
Publications & Presentations
PubMed
- 22 citationsDesign, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.Alberto Fernández-Tejada, Eric K. Chea, Constantine George, Jeffrey Gardner, Philip O. Livingston, Govind Ragupathi, Derek S. Tan, David Y. Gin> ;Bioorganic & Medicinal Chemistry. 2014 Nov 1
- 58 citationsDevelopment of a minimal saponin vaccine adjuvant based on QS-21Alberto Fernández-Tejada, Eric K. Chea, Constantine George, Nagavarakishore Pillarsetty, Jeffrey Gardner, Philip O. Livingston, Govind Ragupathi, Jason S. Lewis, Derek...> ;Nature Chemistry. 2014 Jul 1
- 48 citationsApplying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for OncologyNerissa Viola-Villegas, Samuel L. Rice, Sean Carlin, Xiaohong Wu, Michael J. Evans, Kuntal K. Sevak, Marija Drobjnak, Govind Ragupathi, Ritsuko Sawada, Wolfgang W. Sch...> ;Journal of Nuclear Medicine. 2013 Nov 1
- Join now to see all
Press Mentions
MabVax Therapeutics Grants License to Y-mAbs TherapeuticsJuly 5th, 2018
Grant Support
- Novel Adjuvant Discovery In Vaccine TherapyNational Institute Of Allergy And Infectious Diseases2010–2011
- Characterization Of Human Antibodies To Sialyl-Lewis A (SLEA) Derived From PatienNational Cancer Institute2010
- Immune MonitoringNational Cancer Institute2008–2009
- Regulation By The Immune Response To Vaccines By BotanicalsNational Center For Complementary &Alternative Medicine2007–2009
- Development Of Antibody And T-Cell Inducing VaccinesNational Cancer Institute2005–2009
- Human Monoclonal Antibodies From Immunized Patient LymphocytesNational Cancer Institute2008
- Pilot Trial With A Tetravalent Conjugate Vaccine Against Small Cell Lung CancerNational Cancer Institute2007
- Regulation By Immune Response To Vaccine By BotanicalsNational Center For Complementary &Alternative Medicine2005–2006
- Glycolipid And Protein Vaccines Against CancerNational Cancer Institute2000–2002
- Clinical Trials With Active And Passive Immunotherapy Against Ovarian CancerNational Cancer Institute1998–2002
- Clinical Trials With A Polyvalent Breast Cancer VaccineNational Cancer Institute1997–1999
- Development Of Cancer VaccinesNational Cancer Institute1996–1999
- Construction Of Vaccines Against Breast CancerNational Cancer Institute1994–1996
- Immunization Of Melanoma Patients With GangliosidesNational Cancer Institute1987–1993
- Immunization Of Melanoma Patients With GangliosidesNational Cancer Institute1991
- Augmenting The Immunogenicity Of GangliosidesNational Cancer Institute1987–1989
- Use Of Tumor Associated Antigens As ImmunogensNational Cancer Institute1985–1986
- Treatment Of Suppressor Cell Activity In MelanomaNational Cancer Institute1985
- Serological Response To Renal Cancer VaccinesNational Cancer Institute1985
Professional Memberships
- Fellow
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
